Schaeffer's Top Stock Picks for '25

Analyst: This Overlooked Drug Stock Could Double

The analyst called the stock an "emerging biopharma company"

Digital Content Manager
May 13, 2019 at 11:49 AM
facebook X logo linkedin


H.C. Wainwright just initiated coverage on the drugmaker Rockwell Medical Inc (NASDAQ:RMTI). The brokerage firm started with a "buy" rating and an $11 price target, which is more than double the stock's current levels. The analyst called Rockwell, which specializes in end-stage renal disease treatments, an "emerging biopharma company."

Despite the bull note, RMTI has succumbed to broad market pressure today, down 6.8% at $4.91 at last check. Even with today's drop, the security is still holding atop the $48 region, a long-term level of resistance. Overall, the stock is up nearly 118% this year. 

RMTI Chart May 13

Rockwell Medical has been largely overlooked, with only one "strong buy" rating to its name. The consensus 12-month target price target of $11, however, is at a 124% premium to current levels, and represents an area not touched by the stock since 2015. 

Meanwhile, the 7.23 million shares sold short represents a whopping 16.2% of the stocks available float. At RMTI's average pace of trading, it would take over a month to cover all these pessimistic positions, leaving the door open for a short squeeze.  


 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?